Placebo for AMG 133, AMG 133
20230143
Phase 2 small_molecule active
Quick answer
Placebo for AMG 133, AMG 133 for Type 2 Diabetes Mellitus is a Phase 2 program (small_molecule) at Amgen Technology (Ireland) UC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amgen Technology (Ireland) UC
- Indication
- Type 2 Diabetes Mellitus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active